Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study

[1]  H. D. de Melker,et al.  Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands. , 2016, Vaccine.

[2]  S. Rushton,et al.  Risk factors for the development of pleural empyema in children , 2015, Pediatric pulmonology.

[3]  G. Barnaud,et al.  Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients. , 2014, Journal of critical care.

[4]  Á. Gentile [U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination]. , 2014, Archivos argentinos de pediatria.

[5]  D. Stevens,et al.  Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis. , 2014, The Journal of infectious diseases.

[6]  D. Mant,et al.  Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study. , 2014, The Lancet. Infectious diseases.

[7]  B. Stuart,et al.  Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial , 2013, BMJ.

[8]  W. Keitel,et al.  Influenza A(H5N1) Vaccines: Are We Better Prepared for the Next Pandemic? , 2013, The Journal of infectious diseases.

[9]  C. Brun-Buisson,et al.  Lung abscess complicating pneumococcal pneumonia: a causal role of non-steroidal anti-inflammatory drugs? , 2013, BMJ Case Reports.

[10]  C. Whitney,et al.  U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. , 2013, The New England journal of medicine.

[11]  T. Snelling,et al.  Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine. , 2013, Bulletin of the World Health Organization.

[12]  Yuwei Zhu,et al.  Emergence of parapneumonic empyema in the USA , 2011, Thorax.

[13]  E. Bingen,et al.  PNEUMOCOCCAL MENINGITIS IN FRENCH CHILDREN BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE , 2011, The Pediatric infectious disease journal.

[14]  M. Fartoukh,et al.  Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. , 2011, Chest.

[15]  C. Byington,et al.  Association of 2009 Pandemic Influenza A (H1N1) Infection and Increased Hospitalization With Parapneumonic Empyema in Children in Utah , 2010, The Pediatric infectious disease journal.

[16]  C. Cans,et al.  Prevalence and risk factors of suppurative complications in children with pneumonia , 2010, Acta paediatrica.

[17]  Su-Ting T. Li,et al.  Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine , 2010, Pediatrics.

[18]  Samir S. Shah,et al.  Costs of Treating Children With Complicated Pneumonia: A Comparison of Primary Video‐Assisted Thoracoscopic Surgery and Chest Tube Placement , 2010, Pediatric pulmonology.

[19]  C. O. Solberg Influence of therapeutic concentrations of phenylbutazone on granulocyte function. , 2009, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology.

[20]  C. O. Solberg Influence of phenylbutazone on the phagocytic and bactericidal activities of neutrophil granulocytes. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[21]  S. Saxena,et al.  Effect of Antibiotics for Otitis Media on Mastoiditis in Children: A Retrospective Cohort Study Using the United Kingdom General Practice Research Database , 2009, Pediatrics.

[22]  C. Byington,et al.  Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding Respiratory Viral Infection , 2008, Pediatrics.

[23]  C. Muñoz-Almagro,et al.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Townend,et al.  Trends in pneumonia and empyema in Scottish children in the past 25 years , 2007, Archives of Disease in Childhood.

[25]  Anne M Johnson,et al.  Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database , 2007, BMJ : British Medical Journal.

[26]  S. Suissa,et al.  Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. , 2007, British journal of clinical pharmacology.

[27]  P. Berche,et al.  Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  R. George,et al.  Real-time detection of Mycoplasma pneumoniae in respiratory samples with an internal processing control. , 2006, Journal of Medical Microbiology.

[29]  F. Carrat,et al.  A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure , 2005, Intensive Care Medicine.

[30]  A. Schuchat,et al.  Risk Factors for Pediatric Invasive Group A Streptococcal Disease , 2005, Emerging infectious diseases.

[31]  W. Schaffner,et al.  Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. , 2005, The American journal of medicine.

[32]  P. Apfalter,et al.  Comparison of a New Quantitative ompA-Based Real-Time PCR TaqMan Assay for Detection of Chlamydia pneumoniae DNA in Respiratory Specimens with Four Conventional PCR Assays , 2003, Journal of Clinical Microbiology.

[33]  C. Byington,et al.  An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  R. Borrow,et al.  Simultaneous Detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in Suspected Cases of Meningitis and Septicemia Using Real-Time PCR , 2001, Journal of Clinical Microbiology.

[35]  J. Duchin,et al.  A Case-Control Study of Necrotizing Fasciitis During Primary Varicella , 1999, Pediatrics.

[36]  D. Stevens Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  B. Pennock Effects of Ibuprofen on Endotoxin‐lnduced Alveolitis: Biphasic Dose Response and Dissociation Between Inflammation and Hypoxemia , 1986, The American journal of the medical sciences.

[38]  A. Feinstein,et al.  The problem of "protopathic bias" in case-control studies. , 1980, The American journal of medicine.

[39]  C. O. Solberg,et al.  Influence of phynylbutazone on leukocyte glucose metabolism and function. , 1976, Journal of the Reticuloendothelial Society.

[40]  R. Macgregor,et al.  Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system. , 1974, The New England journal of medicine.

[41]  G. Olsen,et al.  A New Classification of Parapneumonic Effusions and Empyema , 2007 .

[42]  P. Berche,et al.  Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. , 2007, Journal of microbiological methods.

[43]  C. Rouzioux,et al.  Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  L. Woolf Legislation and advances in knowledge--acceleration or inhibition? , 1967, The Journal of pediatrics.